Brainstorm Diagnostics

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://brainstormdx.com/

Last Round

Seed

Dec 14, 2021

Company Overview

Brainstorm Diagnostics is a biotechnology company developing a blood-based biomarker test for the early diagnosis and prognosis of traumatic brain injury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

traumatic brain injuryTBIblood-based diagnosticbiomarkerimmunoassayconcussion testaxonal injurySNTFmedical diagnosticspoint of care testingclinical laboratorybrain injury screeningreference laboratory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brainstorm Diagnostics Comparables

Compare Brainstorm Diagnostics with similar companies based on industry and business-model similarity.

Brainstorm Diagnostics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
bioMérieux	74%
Abbott Laboratories	72%
Quanterix Corporation	63%

View all Comparables

Brainstorm Diagnostics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 14, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Matthew Tormenti

Co-Founder CEO

Founding Team

Brainstorm Diagnostics Investors

Notable investors and investment history

Brainstorm Diagnostics investors
Investor	Rounds
Penn Center for Innovation	Seed

View all Investors

Brainstorm Diagnostics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Brainstorm Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brainstorm Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range3

Year Founded2023

Last FundingDec 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.